CD274 and neoplasm: Recently, mesenchymal tumors have been reported to display higher genomic instability, tumor mutation burden and copy number alterations than other subtypes, while characterized by low immune cells and PDL1 expression, suggesting that they have developed immune-evasive mechanisms contributing to their resistance to immunotherapy [58].